Navigation Links
Ranbaxy joins hand with Cipla to co-market ciprofloxacin

Two of the leading pharmaceutical industries, Ranbaxy Laboratories and Cipla announced an alliance to co-market Ranbaxy’s once-a-day formulation of Ciprofloxacin. The formulation had recently received Drug Controller General of India’s (DCGIs) approval for marketing in India. Ciproloxacin is a unique dosage form of the broad-spectrum antibiotic. The domestic market for ciprofloxacin is estimated to be around Rs 310 crore.

// Ciprofloxacin is the most potent fluoroquinolone with the widest spectrum bactericidal activity. It is a broad spectrum antibiotic. Hence, Ciproflxacin is being extensively used for blind therapy of infections.

According to the company, the alliance with Cipla for ciprofloxacin will be a win-win situation for both companies, enabling to leverage its combined marketing prowess and extensive distribution network. Ranbaxy official said that the company is keen that the benefits of Ciprofloxacin in terms of convenience and better patient compliance should percolate to the maximum number of doctors and patients.

The company believes that the Ciprofloxacin agreement has strengthened the spirit of cooperation that was started a few years ago between Cipla and Ranbaxy. Together, both the company brands account for over 30 per cent of the Ciprofloxacin market in India.

'"/>




Page: 1

Related medicine news :

1. Ranbaxy gets US FDA approval for Lisinopril
2. Ranbaxy Labs Entry Into Anti-Acne Market
3. Ranbaxy trying to make inroads in herbal drugs market
4. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: